The nation of Zimbabwe has rejected a significant US healthcare agreement valued at $367m (272 million pounds) over five years because of Washington's request for confidential biological samples.
This move was revealed after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the agreement was "lopsided".
A government spokesperson has since stated that the US was requesting health data for scientific study and commercial purposes but was unwilling to share the benefits from future medical innovations.
"We will now turn to the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for more talks to find a deal agreeable to both sides so the nation's vital HIV programme can proceed.
Wider Implications
This rejection comes after a similar situation in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were filed about the security of citizens' health data.
Since returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing government-to-government agreements to enhance openness and accountability.
As per statements, 16 African countries have so far signed these new health pacts, constituting more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this cooperation would have delivered immense benefits for the people of Zimbabwe, especially the 1.2 million currently on HIV treatment via American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, with no corresponding guarantee of access to any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.
"Put simply, our country would supply the basic resources for medical research without any certainty that the final treatments would be available to our people if a future disease outbreak arise."
Sovereignty and Global Health
Mangwana further pointed out that the American exit from the global health body and its pursuit of one-on-one deals were undermining frameworks previously established through the international organization.
The spokesperson cited its Pandemic Benefit-Sharing scheme created to manage future global health emergencies.
"This framework is designed to ensure that when a nation provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
The government's concerns over the US deal "must not be interpreted as hostility towards the US," he added.
"We encourage ongoing dialogue with our American counterparts on how future co-operation could be arranged in a way that honours the independence and dignity of both nations."
Health Experts Reaction
A leading public health body expressed it understood the government's concerns, but suggested that negotiations need to persist since much of the country's Aids initiatives depended on international support.
"If technical issues exist, including those involving data governance or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," the group added.
The halted deal underscores the ongoing debate between accepting much-needed foreign assistance and protecting local interests in an increasingly interconnected world.